
Sign up to save your podcasts
Or


On today’s show the guys break down earnings reports from TJX Companies and Home Depot. Plus they take a look at the deal between Allergan and Actavis, and what it all means for the future of Valeant Pharmaceuticals.
By The Motley Fool4.7
16041,604 ratings
On today’s show the guys break down earnings reports from TJX Companies and Home Depot. Plus they take a look at the deal between Allergan and Actavis, and what it all means for the future of Valeant Pharmaceuticals.

3,221 Listeners

1,487 Listeners

808 Listeners

948 Listeners

520 Listeners

1,168 Listeners

2,184 Listeners

825 Listeners

1,423 Listeners

1,039 Listeners

9,717 Listeners

195 Listeners

826 Listeners

85 Listeners

585 Listeners

1,039 Listeners

54 Listeners